Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adjuvant therapy for breast cancer: who should get what?

Literature DB >> 11290691

Adjuvant therapy for breast cancer: who should get what?

H K Chew¹.

Abstract

Entities: Disease

Mesh：

Substances：
Tamoxifen

Year: 2001 PMID： 11290691 PMCID： PMC1071360 DOI： 10.1136/ewjm.174.4.284

Source DB: PubMed Journal: West J Med ISSN： 0093-0415

× No keyword cloud information.

10 in total

1. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

Authors: R Peto; J Boreham; M Clarke; C Davies; V Beral
Journal: Lancet Date: 2000-05-20 Impact factor: 79.321

2. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors:
Journal: Lancet Date: 2000-05-20 Impact factor: 79.321

Review 3. Prognostic factors and treatment decisions in axillary-node-negative breast cancer.

Authors: W L McGuire; G M Clark
Journal: N Engl J Med Date: 1992-06-25 Impact factor: 91.245

4. Breast cancer prognostic factors: evaluation guidelines.

Authors: W L McGuire
Journal: J Natl Cancer Inst Date: 1991-02-06 Impact factor: 13.506

5. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.

Authors: P R Rosen; S Groshen; P E Saigo; D W Kinne; S Hellman
Journal: J Clin Oncol Date: 1989-03 Impact factor: 44.544

6. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors:
Journal: Lancet Date: 1998-05-16 Impact factor: 79.321

7. Underrepresentation of patients 65 years of age or older in cancer-treatment trials.

Authors: L F Hutchins; J M Unger; J J Crowley; C A Coltman; K S Albain
Journal: N Engl J Med Date: 1999-12-30 Impact factor: 91.245

8. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Authors: B Fisher; J P Costantino; D L Wickerham; C K Redmond; M Kavanah; W M Cronin; V Vogel; A Robidoux; N Dimitrov; J Atkins; M Daly; S Wieand; E Tan-Chiu; L Ford; N Wolmark
Journal: J Natl Cancer Inst Date: 1998-09-16 Impact factor: 13.506

9. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.

Authors: B Fisher; C Redmond; E R Fisher; R Caplan
Journal: J Clin Oncol Date: 1988-07 Impact factor: 44.544

10. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors:
Journal: Lancet Date: 1998-09-19 Impact factor: 79.321

10 in total

13 in total

Review 1. Cancer immunotherapy: a promising dawn in cancer research.

Authors: Banashree Bondhopadhyay; Sandeep Sisodiya; Atul Chikara; Asiya Khan; Pranay Tanwar; Dil Afroze; Neha Singh; Usha Agrawal; Ravi Mehrotra; Showket Hussain
Journal: Am J Blood Res Date: 2020-12-15

2. Early downregulation of acute phase proteins after doxorubicin exposition in patients with breast cancer.

Authors: Carolina Panis; Luciana Pizzatti; Aedra Carla Bufalo; Ana Cristina Herrera; Vanessa Jacob Victorino; Rubens Cecchini; Eliana Abdelhay
Journal: Tumour Biol Date: 2015-10-15

3. Indian Solutions for Indian Problems-Association of Breast Surgeons of India (ABSI) Practical Consensus Statement, Recommendations, and Guidelines for the Treatment of Breast Cancer in India.

Authors: S P Somashekhar; Gaurav Agarwal; S V S Deo; P Raghu Ram; Diptendra Sarkar; Vani Parmar
Journal: Indian J Surg Date: 2017-06-22 Impact factor: 0.656

4. PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy.

Authors: Yoon Ah Cho; Seung Yeon Ko; Yong Joon Suh; Sanghwa Kim; Jung Ho Park; Hye-Rim Park; Jinwon Seo; Hyo Geun Choi; Ho Suk Kang; Hyun Lim; Ha Young Park; Mi Jung Kwon
Journal: Curr Oncol Date: 2022-04-19 Impact factor: 3.109

5. Development of Turmeric Oil-Loaded Chitosan/Alginate Nanocapsules for Cytotoxicity Enhancement against Breast Cancer.

Authors: Htet Htet Moe San; Khent Primo Alcantara; Bryan Paul I Bulatao; Waraluck Chaichompoo; Nonthaneth Nalinratana; Apichart Suksamrarn; Opa Vajragupta; Pranee Rojsitthisak; Pornchai Rojsitthisak
Journal: Polymers (Basel) Date: 2022-04-29 Impact factor: 4.967